Please provide your email address to receive an email when new articles are posted on . An ultrathin-strut, biodegradable-polymer sirolimus-eluting stent and a thin-strut, durable-polymer ...

CHICAGO, IL – Two new studies testing first- and second-generation drug-eluting stents (DES) with a bioabsorbable polymer have shown that the two stents are noninferior compared with a durable-polymer ...

The Medtronic Endurant stent graft system got FDA approval to remove a warning against use for ruptured abdominal aortic aneurysms from its label. A retrospective study confirms that women can get ...

A stent that helps keep clogged heart arteries open, then resorbs, appears safe, according to a new study. The study was small, with 50 patients. The follow-up lasted 10 years. The results are called ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. After STEMI, a biodegradable polymer sirolimus-eluting ...

Project - funded by Innovate UK and Medical Research Council Biomedical Catalyst 2018, Round 1 Competition - will see bioresorbable stents treating severe vascular disease and dissolving within two ...

SAN FRANCISCO, CA—The Orsiro biodegradable-polymer, ultrathin-strut, sirolimus-eluting stent (Biotronik) continues to show superiority over the Xience Prime/Xpedition durable-polymer, ...

The latest and largest trial to compare durable-polymer versus biodegradable-polymer stents—this time in the setting of acute coronary syndromes—should convince the field once and for all that a ...

A £1.1 million project to develop biodegradable stents for patients with severe vascular disease, which affects around one million people in the UK, has started thanks to Innovate UK funding. The ...

DUBLIN--(BUSINESS WIRE)--Q3 Medical Devices Limited (“Q3 Medical”) based in Dublin, Ireland, announced today that it has entered into a distribution agreement with Medtronic plc for ARCHIMEDES, the ...

According to the report, the global vascular stents market was valued at US$ 7.6 Bn in 2018 and is projected to expand at a CAGR of ~5% from 2019 to 2027. Rise in prevalence of cardiovascular diseases ...